0 NASDAQ Companies - October 9, 2024Urgently Earns AutoTech Breakthrough Award for ‘Overall Transportation Tech of the Year’VIENNA, Va., Oct. 09, 2024 (GLOBE NEWSWIRE) — Urgent.ly, Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside […]Read More
0 NASDAQ Companies - October 9, 2024Latham Group Appoints New Independent DirectorLATHAM, N.Y., Oct. 09, 2024 (GLOBE NEWSWIRE) — Latham Group, Inc., (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground […]Read More
0 NASDAQ Companies - October 9, 2024LPL Financial Announces Third Quarter 2024 Earnings Release Date and Conference CallSAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), the parent corporation of […]Read More
0 NASDAQ Companies - October 9, 2024Applied Digital Reports Fiscal First Quarter 2025 ResultsDALLAS, Oct. 09, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, […]Read More
0 NASDAQ Companies - October 9, 2024Encore Capital Group to Announce Third Quarter 2024 Financial Results on November 6SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today […]Read More
0 NASDAQ Companies - October 9, 2024Appian To Announce Third Quarter 2024 Financial Results on November 7, 2024MCLEAN, Va., Oct. 09, 2024 (GLOBE NEWSWIRE) — Appian (Nasdaq: APPN) today announced that it will release financial results for […]Read More
0 NASDAQ Companies - October 9, 2024Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024SEATTLE, Oct. 09, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to […]Read More
0 NASDAQ Companies - October 9, 2024Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)BEDFORD, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision […]Read More